MagicTouch SCB receives IDE approval for In-Stent Restenosis indication ...Middle East

PR Newswire - News
MagicTouch SCB receives IDE approval for In-Stent Restenosis indication
TAMPA, Fla., Sept. 17, 2022 /PRNewswire/ -- The US FDA has granted an Investigational Exemption (IDE) approval Device for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR). US FDA's IDE approval allows the MagicTouch SCB to be used in a pivotal clinical...

Hence then, the article about magictouch scb receives ide approval for in stent restenosis indication was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MagicTouch SCB receives IDE approval for In-Stent Restenosis indication )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News